Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TWSE: 1762)
Health Care · Pharmaceuticals · TW
NT$36.30
+3.57% today · +30.6% 1Y
Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TWSE: 1762) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $87.68M and employs 243 people.
Over the last twelve months the share price has gained 30.6%, trading between 24.20 and 44.75.
Tweenvest scores Chunghwa Chemical Synthesis & Biotech Co., Ltd. across four factors: quality 59/100, value 48/100, dividend 36/100. Its strongest factor is quality.
1762 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $87.68M
- Revenue (TTM)
- $29.37M
- P/E
- —
- EPS
- -0.93
- Dividend yield
- 0.53%
- Beta (5Y)
- 0.48
- 52-week high
- NT$44.75
- 52-week low
- NT$24.20
- Avg volume (3M)
- —
- Shares outstanding
- 76.92M
- Employees
- 243
- Next earnings
- —
About Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.
- ISIN
- TW0001762003
- Founded
- 1964
- Listed since
- Dec 20, 2010
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.16 | +0.12% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | 0.00% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.27 | -0.12% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.70 | -0.03% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.52 | -0.99% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.